Matrix-enhancing molecules, such as TGF-, are conjugated to or immobilized on scaffolds to increase ECM production by cells for tissue engineering, tissue regeneration and wound healing applications. The matrix-enhancing molecule is conjugated to a tether, such as polyethylene glycol (PEG) monoacrylate,...http://www.google.es/patents/US20020106793?utm_source=gb-gplus-sharePatente US20020106793 - Tissue engineering scaffolds promoting matrix protein production
Tissue engineering scaffolds promoting matrix protein production
Número de solicitud: 09/935,168 Número de publicación: US 2002/0106793 A1 Fecha de presentación: 21 Ago 2001 Patente emitida: US7635592 ( Fecha de emisión 22 Dic 2009)
